Europe - Frankfurt Stock Exchange - FRA:IX1 - US45168D1046 - Common Stock
The current stock price of IX1.DE is 612.6 EUR. In the past month the price increased by 34.52%. In the past year, price increased by 21.26%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 18.28 | 114.42B | ||
| 1MDT.MI | MEDTRONIC PLC | 18.6 | 114.29B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 17.79 | 47.97B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.23 | 23.13B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.07 | 22.90B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 16.67 | 23.11B | ||
| BIM.PA | BIOMERIEUX | 28.39 | 12.97B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 160 | 4.81B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 26.96 | 4.12B | ||
| DIA.MI | DIASORIN SPA | 18.27 | 3.38B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.83 | 1.31B | ||
| DRW8.DE | DRAEGERWERK AG | 9.46 | 1.14B |
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. Its Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. Its LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve the quality and safety of milk.
IDEXX LABORATORIES INC
One Idexx Drive
Westbrook MAINE US
Employees: 11000
Phone: 12075560300
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. Its Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. Its LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve the quality and safety of milk.
The current stock price of IX1.DE is 612.6 EUR. The price increased by 5.19% in the last trading session.
IX1.DE does not pay a dividend.
IX1.DE has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
IX1.DE stock is listed on the Frankfurt Stock Exchange exchange.
IDEXX LABORATORIES INC (IX1.DE) currently has 11000 employees.
ChartMill assigns a technical rating of 6 / 10 to IX1.DE. When comparing the yearly performance of all stocks, IX1.DE is one of the better performing stocks in the market, outperforming 92.16% of all stocks.
ChartMill assigns a fundamental rating of 7 / 10 to IX1.DE. IX1.DE gets an excellent profitability rating and is at the same time showing great financial health properties.
Over the last trailing twelve months IX1.DE reported a non-GAAP Earnings per Share(EPS) of 9.49. The EPS increased by 11.73% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 22.53% | ||
| ROA | 25.85% | ||
| ROE | 53.54% | ||
| Debt/Equity | 0.48 |
20 analysts have analysed IX1.DE and the average price target is 501.57 EUR. This implies a price decrease of -18.13% is expected in the next year compared to the current price of 612.6.
For the next year, analysts expect an EPS growth of 6.94% and a revenue growth 6.29% for IX1.DE